Table 2 Subgroup analysis according to the type of arrest (OHCA vs. IHCA).
Survival | Neurologic outcomes | ||||||||
---|---|---|---|---|---|---|---|---|---|
Characteristics | N | OR (95% CI) | p value for heterogeneity | I2, % | N | OR (95% CI) | p value for heterogeneity | I2, % | |
OHCA | All | 3 | 2.26 (0.45–11.20) | <0.00001 | 93 | 3 | 3.14 (0.66–14.85) | 0.007 | 80 |
Study type | |||||||||
ROS | 1 | 0.63 (0.39–1.03) | N/A | 1 | 0.94 (0.41–2.14) | N/A | |||
POS | 2 | 4.89 (2.75–8.70) | <0.00001 | 0 | 2 | 7.12 (2.68–18.95) | 0.52 | 0 | |
Assessment of quality | |||||||||
High* | 2 | 1.43 (0.23–9.00) | 0.02 | 83 | 2 | 1.72 (0.38–7.71) | 0.10 | 63 | |
Low | 1 | 5.03 (2.69–9.41) | N/A | 1 | 8.94 (2.69–29.64) | N/A | |||
IHCA | All | 4 | 2.40 (1.44–3.98) | 0.63 | 0 | 3 | 2.63 (1.38–5.02) | 0.36 | 3 |
Study type | |||||||||
ROS | 3 | 2.44 (1.35–4.41) | 0.43 | 0 | 2 | 2.95 (0.19–9.59) | 0.16 | 51 | |
POS | 1 | 2.30 (0.86–6.13) | N/A | 1 | 2.44 (0.88–6.76) | N/A | |||
Assessment of quality | |||||||||
High* | 3 | 2.52 (1.44–4.43) | 0.46 | 0 | 3 | 2.63 (1.38–5.02) | 0.36 | 3 | |
Low | 1 | 1.93 (0.60–6.23) | N/A | — | — | — |